D419NC00001: A Phase 1/2 Study of Durvalumab and IPH2201 in Adult Subjects With Select Advanced Solid Tumors

February 19, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02671435
Cancer - Ovarian, Solid Tumors, Cancer - Colorectal
Principal Investigator: Ding Wang, MD
Cancer, Advanced Solid Tumors, Solid Tumors, Phase I, Phase I, Phase 2, Phase II, Advanced, Select, Ovarian, Colorectal cancer, Colon rectal cancer, Rectal cancer
Open